Author:
Bao Xiuqin,Gao Yuanyi,Wang Zhongju,Ye Yuhua,Chen Diyu,Zuo Yangjin,Zhao Cunyou,Xu Xiangmin
Abstract
AbstractThe mechanism that drives the switch from fetal to adult hemoglobin (Hb) provides a therapeutic target for β-thalassemia. We have previously identified that hypermethylation of transcription factor ERF promoter reactivated γ-globin expression. To uncover the mechanism underlying the hypermethylation of ERF promoter, we performed RNA sequencing in β0/β0-thalassemia patients and identified an upregulated long noncoding RNA (RP11-196G18.23) associated with HbF production. RP11-196G18.23 bound to the ERF promoter and recruited DNA methyltransferase 3A to promote DNA hypermethylation-mediated ERF downregulation, thereby ameliorating ERF-induced γ-globin inactivation. The identification of RP11-196G18.23 provides an epigenetic mechanism for the reactivation of fetal γ-globin expression for β-hemoglobinopathies.
Funder
National Natural Science Foundation of China
Guangzhou Municipal Science and Technology Project
Basic and Applied Basic Research Foundation of Guangdong Province
National Key Research and Development Program of China
Publisher
Springer Science and Business Media LLC